Related Experiment Video
Updated: May 4, 2026
08:14
Rapid Magnetic-microbead Method for Efficient Purification of Low-density Neutrophils
Published on: November 11, 2025
620
Neonatal Fc receptor promotes immune complex-mediated glomerular disease
Florina Olaru1, Wentian Luo1, Hani Suleiman2
1Division of Nephrology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee;
Journal of the American Society of Nephrology : JASN
|December 21, 2013
Summary
The neonatal Fc receptor (FcRn) drives immune complex glomerular disease by maintaining pathogenic IgG levels. Inhibiting FcRn may treat these kidney diseases by reducing IgG and immune complex deposition.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- The neonatal Fc receptor (FcRn) is crucial for regulating IgG and albumin homeostasis.
- Immune complex-mediated glomerular diseases are characterized by antibody and antigen deposition in the kidneys.
Purpose of the Study:
- To investigate the role of FcRn in the development of immune complex-mediated glomerular disease.
- To explore FcRn inhibition as a potential therapeutic strategy for these kidney disorders.
Main Methods:
- Induction of glomerular disease in C57Bl/6 mice using α3NC1 immunization.
- Comparison of disease development in FcRn-null and FcRn-humanized mice.
- Assessment of albuminuria, glomerular deposition, and serum antibody levels.
- Proof-of-concept study using an FcRn-inhibiting peptide.
Main Results:
- α3NC1 immunization induced albuminuria, podocyte injury, and immune complex deposition in wild-type mice.
- FcRn-null and -humanized mice showed no albuminuria and reduced glomerular IgG and complement deposition.
- FcRn inhibition, both genetic and pharmacologic, decreased pathogenic IgG levels and prevented immune complex formation.
Conclusions:
- FcRn plays a critical role in promoting immune complex glomerular disease by sustaining pathogenic IgG levels.
- Pharmacologic inhibition of FcRn represents a promising therapeutic approach for immune complex-mediated kidney diseases.
Related Concept Videos
01:15Transcytosis of IgG
3.4K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.4K
01:27Cytomegalovirus Disease
102
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
01:31Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
01:22Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
01:24Nephrotic Syndrome I : Introduction
1.2K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
01:19Hypersensitivity Reactions: Immune-Complex Reactions
269
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
269